The in Biological Technology
Navigation Links
The in Biological Technology
DOE awards $377 million in funding for 46 energy frontier research centers
... Washington, DC In a major effort to accelerate the scientific breakthroughs needed to build a new ... U.S. Energy Secretary Steven Chu announced the delivery of $377 million in funding for 46 new ... nonprofit organizations, and private firms across the nation. "As global energy demand grows, ...Microparts interest group workshop
... extremely high accuracies. In direct response to the extreme demands of quality assurance for the measurement of size, form and position of ... parts, extensive research is being carried out in the area of geometrical measurement ...... the veil is being lifted from the once unseen world of molecular activity. Not so long ago only the final products were visible and scientists were ...
KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid
... KVa/KVb) (the "Company") today announced that the Company notified certain owners of the Company's Class A and Class B Common Stock, as ... described below (the "Reporting Persons"), that the stockholder action by written consent purported ...Schering-Plough Shareholders Approve Merger With Merck
... Corporation (NYSE: SGP ) announced the voting results of a special shareholders meeting today regarding the proposed merger with Merck & Co., Inc. More than 99 percent of votes cast voted to approve the merger agreement, with more than 78 percent of ...Arizona Pain Specialists Contend Recent Vertebroplasty Studies are Misleading
... -- Two studies released August 6, 2009 in the New England Journal of Medicine claim to ... effective. According to several authorities in the field, this is incorrect, as both studies ... connection because his grandmother recently had the procedure performed with a life-changing, ...REPEL-CV(TM) Adhesion Barrier Receives Endorsement of Kids With Heart
... Board: SYMD), a biomaterials company engaged in the development and commercialization of ... Bioresorbable Adhesion Barrier has received the endorsement of Kids With Heart National ... about this new surgical device that reduces the risks associated with adhesions during repeat ...Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast
... Volcano Corporation (Nadsaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and ... said today that it will be participating in the Canaccord Adams 29th Annual Global Growth ...SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results
... DDD ) today reported financial results for the three and six months ended June 30, 2009. ... and preliminary negotiations of license terms. In the nutraceutical arena, we are working with ... for growing segments of this field in both the US and international markets. We continue to work ...Novavax Reports Second Quarter 2009 Financial Results
... net loss of $8.5 million, or $0.10 per share, for the second quarter of 2009 compared to a net loss of $9.4 million, or $0.15 per share, for the second quarter of 2008. For the six months ended June 30, 2009, Novavax reported ...Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
... Corporation today announced an agreement whereby the Company will re-acquire the distribution rights, along with the trademark, inventory and other assets associated ...... and scientific leadership experience in the biotechnology industry and has served at EGEN ... During his tenure at EGEN he has helped lead the development and testing of proprietary discovery ... on several patents and patent applications in the area of non-viral gene and siRNA delivery. ...
Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results
... CPRX ) today reported financial results for the second quarter and six months ended June 30, ... Second Quarter 2009 Results For the quarter ended June 30, 2009, the Company reported a net loss of $1,761,887, or ...NeurogesX Reports Second Quarter 2009 Results
... management therapies, today reported results for the second quarter ended June 30, 2009 and provided an update on recent accomplishments. During the second quarter of 2009, the European Commission (EC) approved Qutenza in all ...InterMune to Present at Canaccord Adams Conference
... and President of InterMune, will present at the Canaccord Adams 29th Annual Global Growth ... EDT. To access a live audio webcast of the presentation, investors and other interested parties may log on to the investor relations page of InterMune's corporate ...AOBO Announces New Product Launch
... of a broad range of prescription and over the counter ("OTC") products in China, today announced that the Company has launched a new product for the rhinitis and allergy market, called Jingwei ...Viral Genetics Creates Subsidiary to Develop Cancer Therapy
... and radiation therapy to further limit the growth of tumor cells. Dr. Richard J. Trauger, Ph. D., will be chief executive officer of the new company. He will focus on bringing this concept forward into clinic trials and expanding the indications provided ...American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
... of a broad range of prescription and over the counter ("OTC") products in China, today announced financial results for the second quarter ended June 30, 2009. Revenue in the second quarter of 2009 increased 20.7% to $71.2 ...Prix Galien USA Announces 2009 Final Candidates
... NEW YORK, Aug. 7 /PRNewswire-USNewswire/ -- the 2009 Prix Galien USA will recognize innovative ... technologies that have made a deep impact on the quality of human life at a gala event on September 30. Candidates for the 2009 program provide relief to millions of people ...ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA
... Adipone c tin EL I SA kit that facilitates the testing process for this biomarker. This ELISA is ... in a correspondence from Dr. Hiroyuki Ebinuma of the Tsukuba Research Institute in the journal Clinica Chimica Acta in February 2009. ...... million shares of its common stock at a price to the public of $30.50 per share and $200 million ... underwritten public offerings. Onyx has granted the underwriters 30-day options to purchase up to an ... its convertible senior notes in connection with the offerings. Onyx estimates aggregate net proceeds ...
AutoImmune Inc. Reports 2009 Second Quarter Financial Results
... or $0.01 per share basic and diluted, for the three months ended June 30, 2009, compared with a ... or $0.01 per share basic and diluted, for the three months ended June 30, 2008. For the six months ended June 30, ...ThermoGenesis Announces Expanded Collaboration With Celling Technologies
... a subsidiary of SpineSmith, LLC, related to the Company's bone marrow products, MXP(TM) ... ThermoGenesis and Celling will share in the funding for clinical studies to demonstrate the clinical effectiveness of ...Synthetech Reports First Quarter Fiscal 2010 Results
... NZYM) today announced financial results for the first quarter of fiscal 2010, which ended June 30, 2009. Revenue for the quarter was $4.7 million, a 5% decrease compared to revenue of $4.9 million in the first quarter of fiscal 2009. Operating income ...Microbix Sales Grow 22% For Nine Months
... sales and a significantly reduced burn rate. the third quarter had a small sales retraction that ... to timing of orders and changing exchange rates. the forecast is for continued growth in sales. "The 22% sales growth achieved in the nine months ending June 30, 2009 is a trend we ...GenVec Reports Second Quarter 2009 Financial Results
... GNVC ) today announced its financial results for the second quarter ended June 30, 2009. ... a net loss of $4.8 million ($0.05 per share) for the three months ended June 30, 2009 compared to a net loss of $6.6 million ($0.08 per share) in the comparable quarter of 2008. ...Vanda Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 10, 2009
... VNDA ), a biopharmaceutical company focused on the development and commercialization of ... today announced it will release results for the quarter ended June 30, 2009, on Monday, August 10, 2009, before the market opens. A full text copy ...... Novavax, Inc. (Nasdaq: NVAX ) announced today the appointment of Frederick W. Driscoll as Vice ... Laboratory as vice president of finance for the Americas. Dr. Singhvi stated: "We are ... company CFO and has raised significant funds in the capital markets. In addition, he enjoys a strong ...
... (Nasdaq: SIAL ) today announced the acquisition of cheminformatics company, ... and procurement of chemical compound libraries. the acquisition links ChemNavigator's ( ... discovery research programs. Early in the drug discovery process, researchers work ...
... (OTC Bulletin Board: MFLU) announced today that the Company will release second quarter 2009 financial results on Tuesday, August 11, 2009, before the opening of the U.S. financial markets. Michael C. ...
ThermoGenesis Provides Update on Fiscal 2009 Results
... cells, said today that it expects revenues for the fiscal year ended June 30, 2009, will be in the range of $19.5-$20.0 million, subject to final audit adjustments. the Company said revenues ...InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
... ) today announced results from operations for the second quarter and six months ended June 30, 2009. InterMune reported a net loss for the second quarter of 2009 of $36.7 million, or $0.81 ... net loss of $29.6 million, or $0.76 per share, in the second quarter of 2008. Dan Welch, ...SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
... SQNM ), today reported its financial results for the quarter ended June 30, 2009. (Logo: ... Second Quarter Results Total revenue for the second quarter of 2009 was $9.2 million, compared with $12.8 million for the second quarter of ....OncoGenex Reports Second Quarter 2009 Financial Results
... - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" or the "Company") (NASDAQ: OGXI ) today reported unaudited financial results for the second quarter and six months ended June 30, 2009 and reviewed the Company's highlights ...Telik Announces Second Quarter 2009 Financial Results
... net loss of $5.7 million, or $0.11 per share, for the second quarter ended June 30, 2009, compared with ... loss of $13.6 million, or $0.26 per share, for the comparable period in 2008. For the quarter ended June 30, 2009, total operating ...... Analytical Services, Inc. Is Pleased To Announce the Launch Of Its New And Improved Website. the New Site Provides Users With A Comprehensive ... Layout To Enhance Functionality And Navigation. the Site Also Offers An Expanded Service Description ...
Ratcliff Adds Architect John Sealander to Healthcare Practice Group
... Calif., Aug. 6 /PRNewswire/ -- Ratcliff, the award-winning architecture, planning and ... ACHA, NCARB, LEED(R) AP, as a project manager to the firm's healthcare practice group. Ratcliff ( ... academic, and civic clients throughout the Western United States. A licensed ...... release to be issued on Monday, August 10, after the close of the market in New York. the company will host a live webcast of its ...
The Law Offices of Brian D. Witzer Wins 6+ Million Dollar Verdict
... Syndrome/Toxic Epidermal Necrolysis after taking the drug Allopurinol. She alleged that the Defendant, an osteopathic physician and ... it to her for gout. Plaintiff disputed the diagnosis and alleged that she did not have gout. ...... that target cancer stem cells, today announced the publication in Cell Stem Cell of data ... activity in colon and breast cancer models for the company's first product candidate, OMP-21M18, underlining the therapeutic potential of targeting cancer stem ...
Other ContentsglycoproteinglycoproteinglycoproteinglycoproteinglycoproteinglycoproteinglycoproteinapparatusapparatusapparatusapparatusapparatusapparatusapparatusgolgigradientgradientgradientgradientgradientgradientgradientOther TagsRecommendedReddy
(Date:11/24/2009)...able in Spanish . , The presence of increas...matory substances in the blood, hinders the loss a...rch project of the University of Navarra conducted...chool of Pharmacy. , The project, entitled "A nu...he control of body weight and inflammation," exami...
(Date:11/23/2009)...community-associated strain of the deadly superbug...st common antibioticsposes a far greater health th...nto hospitals, according to a study in the Decembe...e new threat is easily picked up in fitness center...sed the overall burden of MRSA within hospitals, t...
(Date:11/23/2009)..., 2009 - The time of day matters to forest trees d...uced by a research team led by Professor Malcolm C...principal for research and colleagues in the depar...e campus. , Capitalizing on their previous wor...earch team examined how poplar trees use their 45,...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin Plasma Protein Fraction 57488 1Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin Plasma Protein Fraction 57488 2Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin Plasma Protein Fraction 57488 3TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 1TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 2TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 3TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 57487 4Cohen Launches Second Statewide Tour 57485 1Cohen Launches Second Statewide Tour 57485 2(Date:11/24/2009)....,Nov.24/PRNewswire/--AgitoNetworks,Inc.,thecompan...,todayannouncedthatitwashonoredintheEverythingChan...reMobilityRouterv3.0.EverythingChannel,sTechInnova...cednewsolutionsthatdriveadvancesthroughoutthetechn...eviewedhundredsofapplicationsforthe2009EverythingC...
(Date:11/24/2009)...4/PRNewswire/--TheUnionLaborLifeInsuranceCompany("...VSP(®),()thenation,slargestvisionbenefitsands...ductstounions,uniontrustfunds,unionemployersandthe...eringservicesincludingcomprehensiveeyeexams,broads...portantqualityeyecareis,"statedBruceSmith,National...
(Date:11/24/2009)...g improves heart prospects, but cancer risk remain...-- A new study offers yet more proof that smoking ...e and cancer. , Researchers followed 12,152 Ame...s smokers and nonsmokers for three years. During t...ely to die of cancer, 2.26 times more likely to di...
(Date:11/24/2009)...e, study finds no added use but higher costs , ...ct-to-consumer drug ads may contribute to higher M...ned sales of the widely used antiplatelet drug clo...1999 to 2005 for 27 state Medicaid programs found ...l did not increase people,s use of the drug but ap...
(Date:11/24/2009)...RNewswire/--TheGuardianLifeInsuranceCompanyofAmeri...leadingproviderofemployeebenefitsforsmallandmid-si...nuetofollowitscurrentinsurancecoverageguidelinesfo...twiththeAmericanCancerSocietyandAmericanMedicalAss...gs. ,, Recently,TheU.S.PreventiveServicesTaskFo...
Breaking Medicine News(10 mins):Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 2Health News:Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 3Health News:Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products 2Health News:Smokers Double Their Risk for Heart Disease 2Health News:Advertising to Consumers May Raise Drug Prices 2[2] Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel[0] Union Labor Life & VSP Vision Care Align to Offer Vision Insurance Products[0] Smokers Double Their Risk for Heart Disease[0] Advertising to Consumers May Raise Drug Prices[0] Guardian to Continue Following Its Current Coverage Guidelines for Mammography Screenings
BroodingPracticingRecommendedCatalogingUvealLouisianaBiometricNexusBritainsBurntReddyBrickbatsNurturingBenetton
Other Tagscomplaining 2complaining 3subjective 2subjective 3earth 2earth 3life 2life 3life 4life 5life 6life 7life 8life 9life 10early 2early 3early 4early 5early 6early 7early 8early 9early 10understanding 2understanding 3understanding 4understanding 5understanding 6understanding 7understanding 8understanding 9understanding 10gain 2gain 3gain 4gain 5gain 6gain 7gain 8gain 9gain 10
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |